Westdorp, Harm <br/><br/>
Blood-derived dendritic cell vaccinations induce immune responses that correlate with clinical outcome in patients with chemo-naive castration-resistant prostate cancer.  [electronic resource] 

 -  Journal for immunotherapy of cancer  11 2019 
 - 302 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>2051-1426 
<br/><br/><label>Standard No.: </label>10.1186/s40425-019-0787-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antigens, Neoplasm--immunology<br/>Cancer Vaccines<br/>Dendritic Cells--immunology<br/>Humans<br/>Kaplan-Meier Estimate<br/>Male<br/>Membrane Proteins--immunology<br/>Middle Aged<br/>Mucin-1--immunology<br/>Neoplasm Proteins--immunology<br/>Prostatic Neoplasms, Castration-Resistant--immunology<br/>Skin--immunology<br/>T-Lymphocytes--immunology<br/>Treatment Outcome<br/>Vaccination--adverse effects